Intervention

active comparator

ClinicalTrials.gov intervention label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 3 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials3

Recruiting0

Common conditions7

Lead sponsors shown3

Clinical trials

3 shown

Staccato Apomorphine Single and Multi Dose PKNCT03822364 · 2018-11-26

COMPLETED

RC2S+: Remediation of Social Cognitive ImpairmentsNCT02976077 · 2016-11-29

COMPLETED

A Study To Examine The Safety, Pharmacokinetics And Pharmacodynamics Of PF-03635659 In Patients With Chronic Obstructive Pulmonary DiseaseNCT01033487 · 2010-01-01

COMPLETED

Common conditions

Chronic Obstructive Airway Disease1 COPD1 Lung Diseases1 Parkinson Disease1 Pulmonary Disease, Chronic Obstructive1 Respiratory Tract Diseases1 Schizophrenia1

Leading sponsors

Alexza Pharmaceuticals, Inc. 1 Hôpital le Vinatier 1 Pfizer 1

Trial status mix

COMPLETED3

Phase mix

NA1

PHASE11

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.